Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Oncology Research|June 21, 2006
Are CYP17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family?Hulya Yazici, Hulya Tigli, Zuleyha Kadehci, et al.
Frontiers in Genetics|May 23, 2015
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign diseaseMustafa Işın, Ege Uysaler, Emre Özgür, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2012
Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancerUgur Gezer, Duran Ustek, Ebru E Yörüker, et al.
Oncology Letters|July 11, 2014
Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapyUgur Gezer, Serkan Keskin, Abdullah Iğci, et al.
In Vivo (Athens, Greece)|November 5, 2004
P53 overexpression in nasopharyngeal carcinomaFulya Yaman Agaoglu, Yavuz Dizdar, Oner Dogan, et al.
Anticancer Research|August 5, 2010
Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patientsYoon Hee Cho, Hulya Yazici, Hui-Chen Wu, et al.
Human Mutation|July 12, 2002
BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial casesHulya Yazici, Gordon Glendon, Hilal Yazici, et al.
Current Issues in Molecular Biology|April 27, 2026
Dysregulation of Aurora Kinases and <i>AURKAIP1</i> Promoter Methylation as Potential Peripheral Diagnostic Biomarkers in Acute Myeloid LeukemiaZubeyde Yalniz Kayim, Seref Bugra Tuncer, Betul Celik Demirbas, et al.
American Journal of Clinical Oncology|March 24, 2012
Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancerYeşim Eralp, Serkan Keskin, Ebru Akışık, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 21, 2015
Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?Merdan Fayda, Mustafa Isin, Makbule Tambas, et al.
Pageof 9